Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	7.50	53.85	50.09
Graham Fair Price	0.00	2.64	2.64
PEG	inf	0.00	-1.27
Price/Book	8.87	2.28	2.09
Price/Cash Flow	8.87	101.21	92.97
Prices/Earnings	8.87	65.34	60.02
Price/Sales	8.87	8.45	7.76
Price/FCF	8.87	101.21	92.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.71	0.71
Operating Margin	0.00	0.14	0.14
ROA	0.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	0.00
ROIC	0.02	0.02	-0.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	< 0.005	451.82
Dividends QOQ	-0.37	0.00	inf
EBIT QOQ	0.48	0.00	inf
EPS QOQ	-0.47	0.00	inf
FCF QOQ	5.35	0.00	inf
Revenue QOQ	0.03	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	525.09	525.09	0.00
Days Sales Outstanding (DSO)	67.72	67.72	0.00
Inventory Turnover	0.17	0.17	0.00
Debt/Capitalization	0.37	0.37	1.14
Quick Ratio	0.60	0.57	-5.07
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	5.96	5.96	0.00
Cash	0.35	0.27	-22.85
Capex	-0.15	-0.15	0.00
Free Cash Flow	0.13	0.13	0.00
Revenue	1.61	1.61	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.77	1.77	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.01	10.21	2.02
Naive Interpretation	Member

06 - Financial Health · Weak

Rating